Cargando…
Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer—How We Can Rise to the Challenge
Triple-negative (TNBC) is the most lethal subtype of breast cancer owing to high heterogeneity, aggressive nature, and lack of treatment options. Chemotherapy remains the standard of care for TNBC treatment, but unfortunately, patients frequently develop resistance. Accordingly, in recent years, tre...
Autores principales: | Nedeljković, Milica, Damjanović, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770896/ https://www.ncbi.nlm.nih.gov/pubmed/31443516 http://dx.doi.org/10.3390/cells8090957 |
Ejemplares similares
-
Vaccines for Gonorrhea: Can We Rise to the Challenge?
por: Zhu, Weiyan, et al.
Publicado: (2011) -
Antimicrobial resistance and inappropriate use of antimicrobials: Can we rise to the challenge?
por: Chandy, Sujith J.
Publicado: (2015) -
How shall we treat locally advanced triple negative breast cancer?
por: Luz, Paulo, et al.
Publicado: (2020) -
Breast cancer resistance to chemotherapy: When should we suspect it and how can we prevent it?
por: Prihantono, et al.
Publicado: (2021) -
Role of PTEN, PI3K, and mTOR in Triple-Negative Breast Cancer
por: Prvanović, Mirjana, et al.
Publicado: (2021)